Ernexa Therapeutics Inc. (ERNA) Net Income by Year
Ernexa Therapeutics Inc. reported a net loss of $14.1M in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ernexa Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ERNA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$14.1M | N/A | -$21.7M+11.8% | -$24.6M+79.9% | -$122.5M-1580.8% | -$7.3M-256.2% | -$2.0M-690.3% | -$259K+76.0% | -$1.1M+63.2% | -$2.9M+59.5% | -$7.2M-43.7% | -$5.0M-377.7% | -$1.1M-5.8% | -$995K+70.9% | -$3.4M |
ERNA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Ernexa Therapeutics Inc. financials
Frequently Asked Questions
What was Ernexa Therapeutics Inc.'s net income in fiscal year 2025?
Ernexa Therapeutics Inc. reported a net loss of $14.1M in fiscal year 2025.
How has Ernexa Therapeutics Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Ernexa Therapeutics Inc. (ERNA) net income went from -$3.4M in fiscal year 2011 to -$14.1M in fiscal year 2025.
What was Ernexa Therapeutics Inc.'s net income in the most recent quarter?
Ernexa Therapeutics Inc. (ERNA) reported -$4.0M in net income in Q2 2026. This represents a decrease of 27.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Ernexa Therapeutics Inc. (ERNA) reported on that line in every period on record.